NCT04075227View on ClinicalTrials.gov

Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 16, 2015

Primary Completion Date

March 2, 2019

Study Completion Date

March 2, 2019

Conditions
Recurrent Pterygium of EyeSteroid-Induced Glaucoma
Interventions
DRUG

0.2% loteprednol etabonate

Use topical 0.2% loteprednol etabonate eyedrop every 4-6 hours for 4 weeks. After that, the regimen was gradually decreased until cessation at 3 months.

DRUG

0.1% dexamethasone

Use topical 0.1% dexamethasone eyedrop every 4-6 hours for 4 weeks. After that, the regimen was gradually decreased until cessation at 3 months.

All Listed Sponsors
collaborator

Srinakharinwirot University

OTHER

lead

Wannisa Suphachearabhan

OTHER

NCT04075227 - Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium | Biotech Hunter | Biotech Hunter